Laserfiche WebLink
Section 1 <br />Company Policy <br />NOTE: In terms of DOT regulations, Section 1 constitutes a "condensed" version of the <br />company's Substance Abuse Program. The entire plan, consisting <br />of Sections 1 thru 5 and referenced DOT regulations, can be obtained by contacting the company's <br />Designated Employer Representative (DER) listed <br />in Section 1, Contacts. <br />Page Contents: <br />4 Notice to Employees <br />5-6 CONTACTS: <br />7 A INTRODUCTION AND GENERAL REQUIREMENTS <br />8 B MATERIALS REQUIRED BY DOT REGULATIONS <br />8 B-1 DESIGNATED EMPLOYER REPRESENTATIVE <br />8 B-2 EMPLOYEES SUBJECT TO THIS POLICY <br />8 B-3 REQUIRED COMPLIANCE PERIODS <br />9-10 B-4 PROHIBITED CONDUCT <br />10-14 B-5 TESTS REQUIRED (pre -employment, post -accident, <br />random, reasonable suspicion, return -to -duty, follow-up) <br />14-18 B-6 TESTING PROCEDURES <br />18 B-7 REQUIREMENT TO SUBMIT TO TESTING <br />18-19 B-8 REFUSAL TO SUBMIT TO TESTING <br />19-20 B-9 CONSEQUENCES OF VIOLATING THIS POLICY <br />20 B-10 ALCOHOL CONCENTRATION OF 0.02 - 0.039 <br />20 B-11 EFFECTS OF ALCOHOL and <br />CONTROLLED SUBSTANCE USE <br />20-21 C OPTIONAL PROVISIONS (stand -down, self -referral) <br />21 D CERTIFICATE OF RECEIPT REQUIREMENT <br />Appendix A - Training Materials/Employees <br />22 Al Alcohol <br />23 A2 Marijuana <br />24 A3 Cocaine <br />25 A4 Amphetamine/Methamphetamine <br />26 A5 Opioids (Morphine/Codeine/Heroin/Other) <br />27 A6 PCP (Phencyclidine) <br />28-32 Appendix B — Supplemental Definitions <br />33 Appendix C — Specimen Collection Synopsis <br />35 Clearinghouse Educational Materials/Receipt <br />37 Certificate of Receipt for Employee's Copy of this Policy <br />39 Post -Accident Test Criteria (Flow Chart) <br />cove DS+Model Program Agreement <br />2020 Drug Screens Plus_ All Rights Reserved. (3) FMCSA 20200101 266 <br />